AstraZeneca Shares Rise for Second Day as Trading Volume Ranks 364th Amid Production Expansion and AI Partnership

AstraZeneca (AZN) shares rose 0.18% on June 9, 2025, marking the second consecutive day of gains, with a total increase of 0.91% over the past two days. The trading volume reached 2.59 billion, ranking 364th in the day's market activity.

Sanofi, in collaboration with AstraZeneca, has significantly increased its production capacity for Beyfortus, tripling output and doubling the number of manufacturing sites. This expansion is aimed at preparing for the respiratory syncytial virus (RSV) season, ensuring a robust supply of the vaccine to meet anticipated demand.

Additionally, AstraZeneca has entered into a landmark three-year, $200 million data and modeling license agreement with Tempus AI and Pathos. This partnership is focused on developing advanced AI-driven solutions to enhance drug discovery and development processes, leveraging Tempus AI's expertise in data analytics and modeling.